newsfilter
← Latest News
Business Wire·

IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results

Achieves fourth quarter revenue growth of 14% as reported and 12% organic, reflecting strong CAG Diagnostics recurring revenue, growing 12% reported and 10% organic. Strong organic growth benefits from IDEXX